The Latest Breaking News from Recession

The German economy has shrunk unexpectedly in the first three months of this year, marking the second quarter of contraction that is one definition of recession

Technical malfunctions have marred Florida Governor Ron DeSantis's announcement that he's running for US president. The hyped Twitter Spaces appearance was 20 minutes late in starting, repeatedly lost sound and many users said they had trouble logging in. Since Elon Musk took the reins, Twitter has struggled with a myriad…

Shares are mostly lower in Europe and Asia as investors watch for signs of progress on a deal to avert a default on U.S. government debt

From social security payments to interest rates, a lot hinges on a debt-ceiling deal. Personal finance experts say you should prepare for a possible debt default as you would a recession.

A quarter of British men say they have no close mates. But even in middle age, where the ‘friendship recession’ hits hardest, it’s possible to buck the trend

Updated data shows economy went into reverse in first quarter with GDP falling by 0.3%

Germany’s slide into recession added to pressure on European markets today as the FTSE 100 index endured another session in the red.

For the third consecutive quarter, the number of times recession is mentioned during earnings calls has fallen, FactSet said.

Shares of Snap (SNAP), the social media darling of Gen Z, have taken a hit as the company is struggling with its widening losses amid the pullback in advertising spend. So, with a recession likely coming this year, is SNAP worth owning? Let’s try to gauge SNAP’s prospects by analyzing…

An asset class recession would hit at a uniquely vulnerable time, as the share of Americans invested in stocks hasn’t been so high since the Great Financial Crisis.

Coupled with the macroeconomic headwinds, the U.S. debt default crisis and consequent recessionary fears have triggered market volatility. Against this backdrop, quality growth stocks Boston Scientific (BSX), Cardinal Health (CAH), Cidara Therapeutics (CDTX), and Geospace Technologies (GEOS) could be solid buys now. Read on….